Protara Therapeutics, Inc. (TARA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Protara Therapeutics, Inc. (TARA) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

TARA Cash Flow Statement

Protara Therapeutics, Inc. (TARA) cash flow statement — 14-year operating, investing & financing cash flows

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Cash from Operations	-18.44M	-15.39M	-21.34M	-16.95M	-12.45M	-12.25M	-14.71M	-9.31M	-8.43M	-7.69M	-10.38M	-8.7M	-6.56M	-9.41M	-12.89M	-5.03M	-5.35M	-5.12M	-10.96M	-6.91M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-48.1%	-25.62%	-45.06%	-82.1%	-47.64%	-59.36%	-41.76%	-6.99%	-28.55%	18.29%	19.47%	-73.1%	-22.7%	-83.64%	-17.58%	27.23%	13.77%	45.93%	8.05%	-2.08%
Net Income	-21.69M	-21.67M	-17.78M	-17.31M	-13.26M	-14.96M	-11.91M	-12.77M	-11.22M	-9.51M	-11.1M	-10.22M	-9.86M	-11.29M	-9.04M	-38.97M	-7.69M	-8.54M	-10.76M	-10.23M
Depreciation & Amortization	71K	72K	90K	93K	88K	98K	83K	82K	84K	83K	83K	107K	107K	420K	77K	-949K	64K	53K	56K	54K
Stock-Based Compensation	1.59M	1.38M	1.36M	1.04M	1.05M	903K	833K	904K	931K	1.06M	1.23M	1.45M	1.45M	0	1.57M	1.43M	1.44M	1.94M	1.88M	1.91M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	-1.01M	0	0	0	0	0	0	0
Other Non-Cash Items	1.19M	120K	93K	-48K	-123K	-99K	97K	-20K	-77K	243K	178K	189K	882K	1.49M	270K	30.99M	614K	688K	751K	457K
Working Capital Changes	403K	4.7M	-5.11M	-731K	-206K	1.81M	-3.81M	2.5M	1.85M	436K	-771K	-227K	1.87M	-19K	-5.76M	2.47M	229K	733K	-2.89M	902K
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	588K	243K	1.09M	-1.56M	-795K	2.99M	-1.5M	1.52M	910K	413K	-1.46M	-70K	652K	-2.23M	2.5M	1.13M	64K	-149K	-413K	26K
Cash from Investing	26.1M	17.75M	-14.72M	-26.91M	-6.51M	-47.72M	-58.35M	22.5M	-29.39M	2.94M	23.1M	14.52M	6.38M	22.35M	9.86M	-18.34M	19.05M	13.5M	745K	1.89M
Capital Expenditures	-723K	-332K	0	-24K	-4K	-22K	-44K	0	-8K	-55K	0	0	-37K	-2K	-6K	-6K	-83K	-20K	-11K	-44K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	412K	-26K	1.14M	80.96M	13K	8K	1.73M	97.85M	0	42.09M	-76K	0	-27K	0	-64K	0	-18K	0	-72K	0
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	0	0	1.42M	80.96M	13K	8K	1.92M	94.04M	0	42.17M	-76K	0	-27K	0	-64K	0	-18K	0	-72K	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	-2K	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	76K	-76K	0	-27K	0	-64K	0	-18K	0	-72K	0
Other Financing	412K	-26K	-272K	0	0	0	-185K	3.81M	0	-83K	0	0	2K	0	0	0	0	0	0	0
Net Change in Cash	8.07M	2.34M	-34.92M	37.11M	-18.95M	-59.97M	-71.34M	111.04M	-37.82M	37.35M	12.64M	5.82M	-210K	12.94M	-3.09M	-23.37M	13.68M	8.38M	-10.29M	-5.02M
Free Cash Flow	-19.16M	-15.72M	-21.34M	-16.97M	-12.46M	-12.27M	-14.76M	-9.31M	-8.44M	-7.74M	-10.38M	-8.7M	-6.6M	-9.41M	-12.89M	-5.03M	-5.43M	-5.14M	-10.97M	-6.95M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-53.86%	-28.1%	-44.63%	-82.36%	-47.55%	-58.51%	-42.18%	-6.99%	-27.95%	17.73%	19.51%	-72.89%	-21.51%	-82.97%	-17.52%	27.61%	11.52%	47.52%	10.14%	4.48%
FCF per Share	-0.30	-0.26	-0.37	-0.37	-0.29	-0.29	-0.36	-0.35	-0.38	-0.36	-0.91	-0.77	-0.58	-0.83	-1.14	-0.45	-0.48	-0.46	-0.98	-0.62
FCF Conversion (FCF/Net Income)	0.85x	0.71x	1.20x	0.98x	0.94x	0.82x	1.23x	0.73x	0.75x	0.81x	0.94x	0.85x	0.67x	0.83x	1.42x	0.13x	0.70x	0.60x	1.02x	0.68x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0